BEIJING | China expects to be in capacity by the end of the year to produce 610 million doses per year of several COVID-19 vaccines, Chinese health officials announced in Beijing on Friday, ensuring that their country is leading in this field.
This annual production should be increased to more than a billion doses by 2021, they added during a press conference.
The development of eleven Chinese vaccines, out of 59 projects in total, has now entered the phase of clinical trials, said Wu Yuanbin, of the Ministry of Health.
“At present, China's COVID-19 vaccine research and development work overall occupies a prominent position,” the same source added.
“We found that the vaccine safety was at a good level and that there were no serious side effects,” Wu Yuanbin said.
Hundreds of thousands of people with jobs deemed essential in ports, hospitals and other high-risk areas have already been experimentally given a vaccine since July, the officials said, according to whom the program has also been administered. support from the World Health Organization (WHO).
“The safety of the vaccine used in the emergency has been fully authenticated, but its effectiveness has not been fully certified,” noted Zheng Zhongwei, of the National Health Commission, promising that the final product would be “Accessible” to the general public.
Two vaccines made by China National Biotec Group (CNBG), a subsidiary of Sinopharm, have been tested on more than 35,000 people in the Middle East, Wu Yuanbin said.
Another major Chinese vaccine producer, Sinovac, has meanwhile carried out trials in South America and Southeast Asia.
A vaccine jointly developed by CanSino Biologics and the Chinese military should also lead to tests abroad, this time in European and Asian countries that have given their consent, according to these officials.
China is in the sights of several Western nations, the United States in the lead, who blame it for reacting too late after the discovery of the new coronavirus in the Chinese city of Wuhan in December 2019.
The development in this country of one or more vaccines against COVID-19 would allow it in this regard to restore its image.